QQQ   435.40 (-0.50%)
AAPL   180.79 (-1.01%)
MSFT   407.18 (-0.07%)
META   485.07 (-0.41%)
GOOGL   136.17 (-1.95%)
AMZN   173.33 (-0.12%)
TSLA   202.20 (+1.24%)
NVDA   782.66 (-0.55%)
NIO   5.46 (-5.54%)
AMD   176.42 (-0.89%)
BABA   74.82 (-3.68%)
T   16.97 (+0.83%)
F   12.38 (+3.17%)
MU   89.71 (-2.33%)
CGC   3.39 (-3.97%)
GE   155.60 (+1.05%)
DIS   110.76 (+1.22%)
AMC   4.86 (+1.04%)
PFE   27.16 (+1.00%)
PYPL   60.40 (+0.40%)
XOM   104.58 (+0.53%)
QQQ   435.40 (-0.50%)
AAPL   180.79 (-1.01%)
MSFT   407.18 (-0.07%)
META   485.07 (-0.41%)
GOOGL   136.17 (-1.95%)
AMZN   173.33 (-0.12%)
TSLA   202.20 (+1.24%)
NVDA   782.66 (-0.55%)
NIO   5.46 (-5.54%)
AMD   176.42 (-0.89%)
BABA   74.82 (-3.68%)
T   16.97 (+0.83%)
F   12.38 (+3.17%)
MU   89.71 (-2.33%)
CGC   3.39 (-3.97%)
GE   155.60 (+1.05%)
DIS   110.76 (+1.22%)
AMC   4.86 (+1.04%)
PFE   27.16 (+1.00%)
PYPL   60.40 (+0.40%)
XOM   104.58 (+0.53%)
QQQ   435.40 (-0.50%)
AAPL   180.79 (-1.01%)
MSFT   407.18 (-0.07%)
META   485.07 (-0.41%)
GOOGL   136.17 (-1.95%)
AMZN   173.33 (-0.12%)
TSLA   202.20 (+1.24%)
NVDA   782.66 (-0.55%)
NIO   5.46 (-5.54%)
AMD   176.42 (-0.89%)
BABA   74.82 (-3.68%)
T   16.97 (+0.83%)
F   12.38 (+3.17%)
MU   89.71 (-2.33%)
CGC   3.39 (-3.97%)
GE   155.60 (+1.05%)
DIS   110.76 (+1.22%)
AMC   4.86 (+1.04%)
PFE   27.16 (+1.00%)
PYPL   60.40 (+0.40%)
XOM   104.58 (+0.53%)
QQQ   435.40 (-0.50%)
AAPL   180.79 (-1.01%)
MSFT   407.18 (-0.07%)
META   485.07 (-0.41%)
GOOGL   136.17 (-1.95%)
AMZN   173.33 (-0.12%)
TSLA   202.20 (+1.24%)
NVDA   782.66 (-0.55%)
NIO   5.46 (-5.54%)
AMD   176.42 (-0.89%)
BABA   74.82 (-3.68%)
T   16.97 (+0.83%)
F   12.38 (+3.17%)
MU   89.71 (-2.33%)
CGC   3.39 (-3.97%)
GE   155.60 (+1.05%)
DIS   110.76 (+1.22%)
AMC   4.86 (+1.04%)
PFE   27.16 (+1.00%)
PYPL   60.40 (+0.40%)
XOM   104.58 (+0.53%)

Allogene Therapeutics (ALLO) Insider Trading & Ownership

$5.15
+0.01 (+0.19%)
(As of 03:04 PM ET)

Allogene Therapeutics (NASDAQ:ALLO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
27.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$93,228.00
Get ALLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ALLO Insider Buying and Selling by Quarter


Allogene Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/18/2023Deborah M MessemerDirectorSell18,640$2.70$50,328.00  
8/7/2023Stephen MayoDirectorSell10,000$4.29$42,900.00  
(Data available from 1/1/2013 forward)












ALLO Insider Trading Activity - Frequently Asked Questions

Who is on Allogene Therapeutics's Insider Roster?

The list of insiders at Allogene Therapeutics includes Alison Moore, Arie Belldegrun, David D Chang, Deborah M Messemer, Eric Thomas Schmidt, Owen N Witte, Rafael Amado, Stephen Mayo, and Veer Bhavnagri. Learn more on insiders at ALLO.

What percentage of Allogene Therapeutics stock is owned by insiders?

27.40% of Allogene Therapeutics stock is owned by insiders. Learn more on ALLO's insider holdings.

Which Allogene Therapeutics insiders have been selling company stock?

The following insiders have sold ALLO shares in the last 24 months: Alison Moore ($66,365.74), David D Chang ($180,907.20), Deborah M Messemer ($50,328.00), Eric Thomas Schmidt ($87,508.47), Owen N Witte ($282,600.00), Rafael Amado ($194,132.99), Stephen Mayo ($42,900.00), and Veer Bhavnagri ($151,813.38).

How much insider selling is happening at Allogene Therapeutics?

Insiders have sold a total of 135,575 Allogene Therapeutics shares in the last 24 months for a total of $1,056,555.78 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ALLO) was last updated on 2/28/2024 by MarketBeat.com Staff